Nemus Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid therapeutics. The company has market cap of $4.43 million. The companyÂ’s product candidates in preclinical stage include NB1111 for the treatment of glaucoma; … Read More
The post Is NEMUS BIOSCIENCE INCORPORATED (OTCMKTS:NMUS) a Buy? The Stock Reported more … appeared first on Dagga Magazine.